Moderna director granted RSUs and stock options

Moderna director Sandra Horning received new equity awards in the form of restricted stock units and stock options.

Rhea-AI Filing Summary

Moderna director Sandra Horning received new equity awards in the form of restricted stock units and stock options. On May 6, 2026 she was granted 2,092 restricted stock units and 9,681 stock options with an exercise price of $48.79 per share, each linked to Moderna common stock.

The restricted stock units convert into common stock on a one-for-one basis and will vest in full on the earlier of May 6, 2027 or Moderna's next Annual Meeting of Shareholders, subject to her continued service. The stock options will become fully vested and exercisable on the same schedule and conditions.

Insider Trade Summary

Grant/Award: 11,773 shares

Grant/Award 2 txns

Insider Horning Sandra

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	9,681	$0.00	$0.00
Grant/Award	Restricted Stock Units	2,092	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 9,681 contracts (Direct); Restricted Stock Units — 2,092 contracts (Direct)

Footnotes (3)

1. F1. This option will become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
2. F2. Restricted stock units convert into common stock on a one-for-one basis.
3. F3. The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Key Figures

RSUs granted: 2,092 units Stock options granted: 9,681 options Option exercise price: $48.79 per share +2 more

5 metrics

RSUs granted 2,092 units Restricted stock units granted May 6, 2026

Stock options granted 9,681 options Stock Option (Right to Buy) granted May 6, 2026

Option exercise price $48.79 per share Conversion/exercise price for stock options

Option expiration date May 6, 2036 Expiration of stock options if unexercised

RSU vesting date Earlier of May 6, 2027 or next meeting Full vesting schedule, subject to continued service

Key Terms

Restricted Stock Units, Stock Option (Right to Buy), vested and exercisable, Annual Meeting of Shareholders, +1 more

5 terms

Restricted Stock Units financial

"The shares subject to this restricted stock unit award will vest in full"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) with an exercise price of 48.7900"

vested and exercisable financial

"This option will become fully vested and exercisable on the earlier of May 6, 2027"

Annual Meeting of Shareholders financial

"on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

one-for-one basis financial

"Restricted stock units convert into common stock on a one-for-one basis."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Moderna (MRNA) director Sandra Horning receive?

Sandra Horning received two equity awards: 2,092 restricted stock units and 9,681 stock options tied to Moderna common stock. These were granted as compensation and are subject to future vesting based on her continued service to the company.

When do Sandra Horning’s new Moderna (MRNA) stock options vest?

Her stock options vest in full on the earlier of May 6, 2027 or Moderna's next Annual Meeting of Shareholders. Vesting is conditional on her continued service, meaning she must remain in her role until that vesting date.

What is the exercise price of Sandra Horning’s Moderna (MRNA) stock options?

The granted stock options have an exercise price of $48.79 per share. This means she can purchase Moderna common stock at $48.79 per share once the options have vested and become exercisable, subject to the award’s terms.

How many restricted stock units did Sandra Horning receive from Moderna (MRNA)?

She received 2,092 restricted stock units. Each unit represents a right to receive one share of Moderna common stock once the award vests in full, assuming she continues her service through the vesting date or the next Annual Meeting.

How do Sandra Horning’s Moderna (MRNA) restricted stock units convert into shares?

The restricted stock units convert into common stock on a one-for-one basis. After they vest on the earlier of May 6, 2027 or the next Annual Meeting, each of the 2,092 units becomes one share of Moderna common stock, subject to plan provisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 05:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Horning Sandra

(Last) (First) (Middle)

C/O MODERNA, INC.

325 BINNEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$48.79	05/06/2026		A		9,681		(1)	05/06/2036	Common Stock	9,681	$0	9,681	D
Restricted Stock Units	(2)	05/06/2026		A		2,092		(3)	(3)	Common Stock	2,092	$0	2,092	D

Explanation of Responses:

1. This option will become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

2. Restricted stock units convert into common stock on a one-for-one basis.

3. The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

	/s/ James Dillon, as Attorney-in-Fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)